The emerging roles of dual-specificity phosphatases and their specific characteristics in human cancer

Ping-Ping Gao1, Xiao-Wei Qi1, Na Sun1

  • 1Breast and Thyroid Surgery, Southwest Hospital, Army Medical University, Chongqing 400038, China.

Insights

Dual-specificity phosphatases (DUSPs) are crucial in cellular processes and cancer. This review systematically examines DUSP functions, mechanisms, and clinical applications, highlighting their potential as cancer biomarkers and therapeutic targets.

Area of Science:

  • Molecular Biology
  • Biochemistry
  • Oncology

Background:

  • Reversible protein phosphorylation by kinases and phosphatases regulates cellular functions.
  • Dual-specificity phosphatases (DUSPs) dephosphorylate serine, threonine, and tyrosine residues.
  • DUSP dysregulation is common in human cancers, with potential prognostic value.

Purpose of the Study:

  • To systematically review DUSP structures, functions, and mechanisms in cancer.
  • To summarize DUSP roles and characteristics across various tumor types.
  • To explore unstudied DUSP members and their potential in cancer biology and clinical applications.

Main Methods:

  • Systematic literature review of DUSP functions and mechanisms.
  • Homology alignment and structural domain analysis for DUSP classification.
  • Analysis of DUSP expression and prognosis in over 30 human cancers using online databases.

Main Results:

  • DUSPs play significant roles in human cancers, with differential expression linked to prognosis.
  • Current research is limited on many DUSP members, necessitating further investigation.
  • DUSP expression patterns and prognostic significance vary across different cancer types.

Conclusions:

  • DUSPs represent promising biomarkers for precise cancer diagnosis and prognosis.
  • Understanding DUSP mechanisms offers potential for novel cancer therapeutic strategies.
  • Further research is needed to overcome challenges in the clinical application of DUSPs.

Related Concept Videos

Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
14.0K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

4.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.8K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
3.3K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.5K